Vantictumab
Product Specifications
CAS Number
1345009-45-1
Target
Wnt/beta-catenin
Related Pathways
Cytoskeletal Signaling, Stem Cells
Purity
0.99
Bioactivity
Vantictumab (OMP-18R5) is a humanized anti-FZD1/2/5/7/8 monoclonal antibody that inhibits Wnt pathway signaling and is used in research studies for the treatment of metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
